SEMA3A and Hypoglycemia: Here we report the levels of soluble neuropilin-1 (sNRP1), NRP1 proteolytic enzyme ADAM9 and NRP1 ligands, VEGF and SEMA3A, in response to insulin-induced hypoglycemia in obese patients with T2D.